NCT07205341Recruiting
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
HemoCept Inc.
Start Date
4/29/2025
Completion Date
9/1/2026
Summary
The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.
Eligibility Criteria
Age Range: 18 years to 80 years
Inclusion Criteria:
* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be between (and including) the ages of 18 and 80.
* Subject ls being treated by the participating healthcare facility .
., Subject requires a trans-aortic valve replacement.
* Subject is able and willing to provide informed consent and HIPM authorization.
* Subject is able and willing to meet all study requirements.
Exclusion Criteria:
* Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
* Subject has a personal medical history that includes:
* Long O-T syndrome
* Cardiac channelopathies
* Seizures
Conditions
Aortic Valve Stenosis
Locations
Boulder Heart
Boulder, Colorado 80303
United States